Live News EQUITY FLASH L impact Nov 19, 2026, 01:44 PM UTC GE Healthcare’s Mangaciclanol Meets Primary Endpoint in Phase 2 Study Valid market news retained in the public archive without immediate LiveCast distribution. GEHC SquawkNews Desk